Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2012
02/29/2012CN101768147B Chrysin and substituted salicylate composites, manufacturing method thereof and use thereof
02/29/2012CN101671319B Taxus nontoxic extract process
02/29/2012CN101669992B Distinguishing method and measuring method of perilla leaf oil
02/29/2012CN101628903B Defervescence anti-inflammatory and anti-infection medicine with immunization function, preparation and application thereof
02/29/2012CN101590152B Preparation method of Bawei Chenxiang capsule
02/29/2012CN101496636B Method for preparing and using functional plant stuffing for thin sheet raw material of paper-making process
02/29/2012CN101400659B Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
02/29/2012CN101327288B Method for preparing Liaoyuanqili super fine powder
02/29/2012CN101244051B Actarit cyclodextrin, clathrate compound of cyclodextrin derivant and preparation thereof
02/29/2012CN101204421B Traditional Chinese traditional medicine composition for dispelling wind, activating blood circulation, stopping pain and preparation method thereof
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124614 Steroidal compounds for inhibiting steroid sulphatase
02/28/2012US8124586 Prevention and reduction of blood loss
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia
02/28/2012US8124133 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect
02/28/2012US8124124 Compressed tablet containing non-steroid antiinflammatory drug
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/28/2012US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making
02/23/2012WO2012024559A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012WO2012024530A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
02/23/2012WO2012024150A1 Oxadiazole inhibitors of leukotriene production
02/23/2012WO2012023254A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid
02/23/2012WO2012023146A1 A pharmaceutical composition of reformulated turmeric extract and a method thereof
02/23/2012WO2012022837A1 Transdermal compositions
02/23/2012WO2012022795A1 Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor
02/23/2012WO2012022793A1 New compounds
02/23/2012WO2012022792A1 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors
02/23/2012WO2012022487A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/23/2012WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2011158044A3 Respiratory formulations containing p38 mapk inhibitors
02/23/2012WO2011133385A3 Novel ether-based compounds and their use
02/23/2012US20120046441 Combinatorial Synthesis of Libraries of Macrocyclic Compounds Useful in Drug Discovery
02/23/2012US20120046368 Method for purifying 3,4-dihydroxyphenylglycol (dhpg) from plant products
02/23/2012US20120046366 Extractions of Fixed Oil and Thymoquinone Rich Fractions (TQRF)
02/23/2012US20120046357 Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
02/23/2012US20120046351 Medicinal cannabis added in food
02/23/2012US20120046343 MULTI-TARGETING SHORT INTERFERING RNAs
02/23/2012US20120046342 Oligonucleotide comprising an inosine for treating dmd
02/23/2012US20120046329 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/23/2012US20120046325 Isoxazoline Compounds Having MIF Antagonist Activity
02/23/2012US20120046322 Bioavailable Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
02/23/2012US20120046319 Process for the preparation of enantiomerically enriched proton pump inhibitors
02/23/2012US20120046316 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/23/2012US20120046311 Chemokine receptor antagonists and methods of use thereof
02/23/2012US20120046307 Allosteric protein kinase modulators
02/23/2012US20120046303 Benzimidazole poly(adp ribose)polymerase inhibitors
02/23/2012US20120046301 Substituted Cyclic Carboxamide and Urea Derivatives as Ligands of the Vanilloid Receptor
02/23/2012US20120046298 Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
02/23/2012US20120046290 Inhibition of p38 kinase activity using substituted heterocyclic ureas
02/23/2012US20120046286 Novel Compounds
02/23/2012US20120046284 Salts and hydrates of 4-[(3-chloro-4-fluoro-phenyl)amino]-6-(cis-4--cyclohexan-1-yloxy)-7-methoxy-quinazoline, their use as a medicament and the preparation thereof
02/23/2012US20120046280 Novel heteropyrrole analogs acting on cannabinoid receptors
02/23/2012US20120046272 Novel Therapeutic Compounds
02/23/2012US20120046270 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
02/23/2012US20120046269 Novel Amino Azaheterocyclic Carboxamides
02/23/2012US20120046267 7-aminofuropyridine derivatives
02/23/2012US20120046258 Novel crystalline pharmaceutical product
02/23/2012US20120046255 Non-steroidal compounds
02/23/2012US20120046246 Methods for treating osteoclast-related disease, compounds and compositions thereof
02/23/2012US20120046245 Compositions and methods for inhibition of the jak pathway
02/23/2012US20120046236 Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
02/23/2012US20120046230 Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
02/23/2012US20120046218 Glycosaminoglycan-antagonising mcp-i mutants and methods of using same
02/23/2012US20120046217 TNF-alpha Antagonists Containing IGFBP5
02/23/2012US20120045507 Stable soft capsule dosage form for acetylsalicylic acid
02/23/2012US20120045505 Fixed dose drug combination formulations
02/23/2012US20120045490 Compositions comprising paulownia tomentosa wood extracts and uses thereof
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045484 Calcium phosphate/sulfate-based bone implant composition
02/23/2012US20120045481 Preventive and/or ameliorative agent for diseases, stamina enhancement agent, anti-fatigue agent, and pharmaceutical and food and drink using them
02/23/2012US20120045462 Inflammation Inhibiting Compounds
02/23/2012US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival
02/23/2012US20120045458 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22
02/23/2012US20120045454 2,4-pyrimidinediamine compounds and their uses
02/23/2012US20120045449 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
02/23/2012US20120045441 Methods of treating lung disease and other inflammatory diseases
02/23/2012US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012US20120045428 Methods for preparing a fermented ginseng concentrate or powder
02/23/2012US20120045418 Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
02/23/2012US20120045417 Methods and compositions for islet cell preservation
02/23/2012US20120045407 Compositions comprising paulownin and/or paulownia extracts and uses thereof
02/23/2012US20120045404 Bioactive compositions from theacea plants and processes for their production and use
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
02/23/2012CA2808798A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012CA2808543A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012CA2807364A1 Oxadiazole inhibitors of leukotriene production
02/23/2012CA2807089A1 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors
02/23/2012CA2806634A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
02/23/2012CA2804575A1 New compounds
02/22/2012EP2420490A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof
02/22/2012EP2419425A1 Imidazole substituted pyrimidines useful in the treatment of glycogen synthase kinase 3 related disorders such as alzheimer's disease
02/22/2012EP2419419A1 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/22/2012EP2419418A1 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
02/22/2012EP2419417A1 4-azetidinyl-1-heteroaryl-cyclohexane antagonists of ccr2
02/22/2012EP2419404A1 Anti-viral compounds
02/22/2012EP2419146A1 Modulation of inflammatory responses by factor xi
02/22/2012EP2419121A2 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
1 ... 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 ... 1272